Turin · Pre-Seed–Series A · 14 people tracked
Investment thesis
Claris Ventures backs early-stage biopharma companies that combine a clear vision with solid scientific evidence. The firm targets innovators addressing significant unmet clinical needs across areas including rare diseases, oncology and immunology, as well as other life-threatening disease areas. Beyond capital, Claris provides scientific competence and hands-on support to help jump-start clinical development programs, aiming to create value driven by clinical evidence. Its fund, Claris Biotech I, is backed by European institutional programs including InnovFin Equity under Horizon 2020, the European Fund for Strategic Investments, AlpGIP, and the Pan-European Guarantee Fund.
Source: firm website, verified Aug 3, 2026.
Team · 14 people
from the firm's website & public directories
What they invest in
from 7 of 11 portfolio companiesBiotech ×7Healthtech ×4Deep Tech ×2Medical Devices ×2AI & Machine Learning ×1Digital Health ×1
HQs:Italy×1
Investments · 11 tracked
founders shown can be your intro path
ALKemist Bio develops immunotherapies targeting ALK-positive cancers, using chimeric antigen receptor (CAR) T cells and T cell receptor (TCR) engineered T cells to eliminate treatment-resistant tumors.
BiotechDigital HealthMedical Devices
Co-investorsClub degli InvestitoriItalian Angels for GrowthLIFTT
Co-investorsNeva Sgr.
Heqet Therapeutics is a pre-clinical stage biotech developing non-coding RNA-based therapies for cardiovascular diseases, with a focus on acute myocardial infarction.
BiotechMedical Devices
Mauro Giacca(Founder (Professor of Cardiovascular Sciences))
Co-investorsCDP Venture CapitalIndaco Venture Partners
Co-investors3B Future Health FundCDP Venture CapitalElysia CapitalItalian Angels for Growth
Lever Bio is an immuno-oncology company developing compounds that reprogram the solid tumor microenvironment to enhance the recruitment, activation, and function of cytotoxic T lymphocytes against solid tumors.
BiotechDeep TechHealthtech
Co-investorsItalian Angels for Growth
Co-investors3B Future Health FundAstellas Venture Management LLCNeva Sgr.
PAGE Therapeutics is an oncology drug development company developing compounds that disrupt cell-cell adhesion to dissolve circulating tumor cell (CTC) clusters and block cancer metastasis.
BiotechHealthtech
Nicola Aceto(Co-founder & Chief Science Officer)Christoph Rochlitz(Co-founder & Chief Medical Officer)Daniele Scarinci(CEO & Executive Director)inKatharina Venturi(Chief Operating Officer)
Co-investorsXGEN Venture
Resalis Therapeutics develops RNA-based therapies targeting non-coding RNAs to address the underlying causes of complex metabolic disorders.
BiotechHealthtech
Co-investorsItalian Angels for GrowthSunstone Capital
Sibylla Biotech develops PPI-FIT, a drug discovery technology that uses quantum physics and mathematical modeling to characterize protein folding pathways at atomic resolution.
AI & Machine LearningBiotechDeep TechTrento, IT
Emiliano Biasini(Co-founder)Pietro Faccioli(Co-founder)Giovanni Spagnolli(Co-founder, CTO)Maria Letizia Barreca(Co-founder)Graziano Lolli(Co-founder)
Co-investors3B Future Health FundCDP Venture CapitalSeroba Life SciencesV-Bio VenturesVertis SGRVI Partners
Frequently asked questions
- How many investments has Claris Ventures made?
- Claris Ventures has 11 tracked investments.
- What stage does Claris Ventures invest at?
- Claris Ventures invests at the Pre-Seed, Seed, Series A stages.
- What sectors does Claris Ventures focus on?
- Claris Ventures focuses on Biotech, Healthtech, Medical Devices.
- Where is Claris Ventures located?
- Claris Ventures is headquartered in Turin, IT.
- Does Claris Ventures lead rounds?
- Claris Ventures typically participates in rounds rather than leading them.
- Who does Claris Ventures co-invest with?
- Claris Ventures most often shares deals with Italian Angels for Growth, 3B Future Health Fund, CDP Venture Capital, among 12 tracked co-investors.
Media · Podcasts & interviews
featuring the teamPietro Puglisi (Claris Ventures): Sostenere la crescita e dare visione con investimenti nel settore
Sanità33 · Pietro Puglisi
Images
Co-investors · 3
CDP Venture Capital SGR is an Italian venture capital fund manager that invests in strategic sectors for Italy's economic growth through direct and indirect funds. It is Italy's leading VC fund manager and among the largest in Europe.
3B Future Health Fund invests in early-stage private healthcare and biotech companies in the US, Europe and Israel that address high unmet patient needs, with a focus on oncology and rare diseases.
Seroba is a Dublin-based life sciences venture capital firm investing in early-stage biotech and medtech companies developing new therapeutics and medical devices.
Firms observed investing alongside Claris Ventures, from public investor directories. Shared companies are the overlap with Claris Ventures's recorded portfolio.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.